Medicare compliance landmines, hidden audit liability, and census volatility can destroy returns. Here's how experienced acquirers protect themselves.
Find Vetted Hospice & Palliative Care DealsHospice acquisitions offer compelling margins and recession-resistant demand, but Medicare reimbursement complexity, OIG scrutiny, and clinical staffing fragility create risks that sink unprepared buyers. These six mistakes separate costly deals from successful platforms.
Market Size
Approximately $22–25 billion annually in the U.S., with Medicare funding the vast majority of hospice care expenditures
Growth Trend
Growing
Recession Resistant
Yes
Market Structure
Highly fragmented
Buyers routinely miss that a hospice approaching its annual Medicare aggregate cap faces revenue recoupment. Unresolved RAC audit findings or prior overpayment demands can become the buyer's liability post-close.
How to avoid: Request three years of Medicare cost reports, calculate current cap utilization, and require escrow holdbacks in the purchase agreement sized to cover realistic recoupment exposure.
Medicare Change of Ownership approval is not automatic. Buyers who close without a fully executed CHOW strategy risk billing interruptions, census erosion, and compliance violations during the transition period.
How to avoid: Engage a healthcare attorney experienced in Medicare CHOW before LOI. Build a 90–120 day CHOW timeline into your close schedule and maintain billing continuity agreements with the seller.
Sellers often normalize for owner compensation but obscure bloated contract labor costs or understaffed positions. Reported EBITDA may assume a staffing model that cannot sustain census post-acquisition.
How to avoid: Reconcile payroll records against ADC trends. Benchmark staff-to-patient ratios against CMS conditions of participation and validate that clinical capacity supports the stated patient census.
A hospice deriving more than 20% of admissions from a single hospital, SNF, or physician group is dangerously exposed. Referral relationships are personal and rarely transfer automatically to new ownership.
How to avoid: Map 24 months of admission data by referral source. Require seller-facilitated introductions during diligence and structure earnouts tied to census retention from top referral relationships.
Hospice referral relationships with physicians and SNFs carry anti-kickback statute risk. Undisclosed gifts, meals, or below-market lease arrangements with referral sources can expose the buyer to federal enforcement liability.
How to avoid: Request a compliance program review including policies, training records, and any prior OIG disclosures. Have healthcare counsel audit referral source contracts for safe harbor compliance.
Directors of Nursing, administrators, and tenured field nurses hold the referral relationships and clinical reputation of the agency. Their departure post-close can collapse census within 90 days.
How to avoid: Identify key clinical personnel during diligence. Negotiate stay bonuses, employment agreements, and equity participation for the DON and administrator as conditions of deal close.
Buyers submit SBA loan applications before independently verifying the Hospice & Palliative Care's normalized EBITDA. When diligence reveals add-backs that don't hold, the deal's debt service coverage collapses and the loan fails underwriting.
How to avoid: Build your EBITDA model with conservative add-back assumptions before engaging an SBA lender. At current rates, a $1M SBA 7(a) loan costs approximately $13,000/month — the Hospice & Palliative Care needs $195,000+ in post-salary EBITDA to clear 1.25x DSCR.
Buyers close on a Hospice & Palliative Care assuming operations transfer smoothly, then discover undocumented processes, informal vendor relationships, and staff who rely on institutional knowledge the seller carries in their head.
How to avoid: Require a 60-day operational documentation period before closing. Walk through every key process with the seller present, document staff responsibilities, vendor contacts, and customer communication protocols. Build a 90-day integration plan before the wire hits.
What experienced buyers verify before committing to a Hospice & Palliative Care acquisition.
The specific concerns and miscalculations buyers face in this industry.
Common miscalculations sellers make that reduce their final price or derail a deal.
Yes. SBA 7(a) loans are available for qualifying hospice acquisitions. Lenders will scrutinize Medicare reimbursement stability, compliance history, and EBITDA consistency. Clean cost reports and no active audits are essential for approval.
Asset purchases with escrow holdbacks sized to potential recoupment exposure are most protective. Include Medicare audit representations, indemnification carve-outs for pre-close billing periods, and a seller note subordinated to compliance contingencies.
CHOW approval through CMS and the MAC typically takes 60–120 days. Buyers should plan for billing interruption risk and negotiate interim management or billing agreements with sellers to maintain cash flow continuity during the process.
Clean Medicare-certified hospice agencies with stable ADC and diversified referrals trade at 4x–7x EBITDA. Compliance risk, cap exposure, or referral concentration compress multiples toward the lower end of that range.
More Hospice & Palliative Care Guides
DealFlow OS helps you find and evaluate acquisitions with seller signals and due diligence tools. Free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers